Regulations.gov document
Real-World Data: Assessing Registries To Support Regulatory Decision-Making for Drug and…
Notice · FDA-2021-D-1146 · posted Nov 30, 2021
Key facts
| Document ID | FDA-2021-D-1146-0001 |
|---|---|
| Title | Real-World Data: Assessing Registries To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2021-D-1146 |
| Posted | Nov 30, 2021 |
| Federal Register citation | 86 FR 67956 |
| FR document number | 2021-26006 |
| Comment period opens | Nov 30, 2021 |
| Comments due | Mar 1, 2022 |
| Effective date | Nov 30, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: